Subheading · Chapter 30 · Heading 3002
3002.15: Immunological products, put up in measured doses or in forms or packings for retail sale
Immunological products, dosed or retail
3002.15 is the HS subheading for immunological products, dosed or retail, under heading 3002 in chapter 30.
What you pay
Importing into UK
Rates by national line · UK Global Tariff
UK lines →- 3002 15 00 00 Immunological products, put up in measured doses or in forms or packings for retail sale Free
Additional duties and import rules
Charges on top of the customs duty, and rules the goods must meet at the border.
Additional duties and charges 1
- Additional dutyAdditional duties 35%
- Applies to goods from
- Belarus, Russia
- Legal act
- 2022 No. 598
- Documents
- 9014
Import requirements 2
- Import controlRestriction on entry into free circulation
- Applies to goods from
- Ukraine
- Legal act
- S.I. 2022/395
- Documents
- 9009
- 9010
- 9017
- Import controlImport control - CITES
- Applies to goods from
- all countries
- Legal act
- 2021 No. 54
Preferential rates by country
| Agreement or scheme | Countries | Rate |
|---|---|---|
| standard rate (no agreement) | — | Free |
| DCTS Comprehensive | Afghanistan, Angola, Bangladesh, Benin and 38 moreAfghanistan, Angola, Bangladesh, Benin, Bhutan, Burkina Faso, Burundi, Cambodia, Central African Republic, Chad, Comoros, Congo - Kinshasa, Djibouti, Eritrea, Ethiopia, Gambia, Guinea, Guinea-Bissau, Haiti, Kiribati, Laos, Liberia, Malawi, Mali, Mauritania, Myanmar (Burma), Nepal, Niger, Rwanda, São Tomé & Príncipe, Senegal, Sierra Leone, Somalia, South Sudan, Sudan, Tanzania, Timor-Leste, Togo, Tuvalu, Uganda, Yemen, Zambia | Free |
| European Union (including code "EU") | Free | |
| CARIFORUM | Antigua & Barbuda, Bahamas, Barbados, Belize and 10 moreAntigua & Barbuda, Bahamas, Barbados, Belize, Dominica, Dominican Republic, Grenada, Guyana, Jamaica, St Kitts & Nevis, St Lucia, St Vincent & the Grenadines, Suriname, Trinidad & Tobago | Free |
| OCTs (Overseas Countries and Territories) | Anguilla, Bermuda, British Indian Ocean Territory, British Virgin Islands and 7 moreAnguilla, Bermuda, British Indian Ocean Territory, British Virgin Islands, Cayman Islands, Falkland Islands, Montserrat, Pitcairn Islands, South Georgia & South Sandwich Islands, St Helena, Turks & Caicos Islands | Free |
| Central America | Costa Rica, El Salvador, Guatemala, Honduras, Nicaragua, Panama | Free |
| SADC EPA | Botswana, Eswatini, Lesotho, Mozambique, Namibia | Free |
| Eastern and Southern Africa States | Madagascar, Mauritius, Seychelles, Zimbabwe | Free |
| CPTPP | Brunei, Malaysia | Free |
| UK–Andorra agreement | Andorra | Free |
| UK–Albania agreement | Albania | Free |
| UK–Australia agreement | Australia | Free |
| UK–Canada agreement | Canada | Free |
| UK–Switzerland agreement | Switzerland | Free |
| UK–Côte d’Ivoire agreement | Côte d’Ivoire | Free |
| UK–Chile agreement | Chile | Free |
| UK–Cameroon agreement | Cameroon | Free |
| UK–Colombia agreement | Colombia | Free |
| UK–Ceuta & Melilla agreement | Ceuta & Melilla | Free |
| UK–Ecuador agreement | Ecuador | Free |
| UK–Egypt agreement | Egypt | Free |
| UK–Fiji agreement | Fiji | Free |
| UK–Faroe Islands agreement | Faroe Islands | Free |
| UK–Georgia agreement | Georgia | Free |
| UK–Ghana agreement | Ghana | Free |
| UK–Israel agreement | Israel | Free |
| UK–India agreement | India | Free |
| UK–Iceland agreement | Iceland | Free |
| UK–Jordan agreement | Jordan | Free |
| UK–Japan agreement | Japan | Free |
| UK–Kenya agreement | Kenya | Free |
| UK–South Korea agreement | South Korea | Free |
| UK–Lebanon agreement | Lebanon | Free |
| UK–Liechtenstein agreement | Liechtenstein | Free |
| UK–Morocco agreement | Morocco | Free |
| UK–Moldova agreement | Moldova | Free |
| UK–North Macedonia agreement | North Macedonia | Free |
| UK–Mexico agreement | Mexico | Free |
| UK–Norway agreement | Norway | Free |
| UK–New Zealand agreement | New Zealand | Free |
| UK–Peru agreement | Peru | Free |
| UK–Papua New Guinea agreement | Papua New Guinea | Free |
| UK–Palestinian Territories agreement | Palestinian Territories | Free |
| UK–Serbia agreement | Serbia | Free |
| UK–Solomon Islands agreement | Solomon Islands | Free |
| UK–Singapore agreement | Singapore | Free |
| UK–San Marino agreement | San Marino | Free |
| UK–Tunisia agreement | Tunisia | Free |
| UK–Türkiye agreement | Türkiye | Free |
| UK–Ukraine agreement | Ukraine | Free |
| UK–Vietnam agreement | Vietnam | Free |
| UK–Samoa agreement | Samoa | Free |
| UK–Kosovo agreement | Kosovo | Free |
| UK–South Africa agreement | South Africa | Free |
UK: imports by month
Main suppliers, last 12 months
| Country | Value | Share | Change |
|---|---|---|---|
| £946.8m | 18.7% | +12.7% | |
| £838.6m | 16.5% | +22.4% | |
| £836.3m | 16.5% | +34.7% | |
| £774.5m | 15.3% | -4% | |
| £543.7m | 10.7% | +50.7% | |
| £289.5m | 5.7% | +7.6% | |
| £278.1m | 5.5% | +38.4% | |
| £121.7m | 2.4% | +91.7% |
Same subheading in other tariffs
World trade in 2024
Trade value (US$) no reported trade < US$1mUS$1m+US$74m+US$4bn+> US$19bn
Exports: 128
- Switzerland: US$34bn
- Germany: US$31bn
- United States: US$20bn
- Ireland: US$19bn
- Netherlands: US$11bn
- Belgium: US$10bn
- Italy: US$8bn
- Japan: US$7bn
- Austria: US$5bn
- South Korea: US$5bn
- United Kingdom: US$4bn
- France: US$4bn
- Sweden: US$3bn
- Hungary: US$2bn
- Denmark: US$2bn
- Slovenia: US$1bn
- Singapore: US$1bn
- Poland: US$1bn
- Spain: US$619m
- China: US$502m
- Portugal: US$419m
- India: US$356m
- Türkiye: US$310m
- Croatia: US$303m
- Iceland: US$263m
- Czechia: US$216m
- Costa Rica: US$187m
- Israel: US$116m
- Lithuania: US$106m
- Canada: US$74m
- Ukraine: US$72m
- Slovakia: US$63m
- Russia: US$42m
- Hong Kong SAR China: US$41m
- Australia: US$37m
- Argentina: US$37m
- Taiwan: US$34m
- Finland: US$33m
- Romania: US$31m
- Bulgaria: US$23m
- Greece: US$19m
- Estonia: US$13m
- Latvia: US$13m
- South Africa: US$10m
- Iran: US$7m
- New Zealand: US$7m
- Uruguay: US$6m
- Brazil: US$5m
- Norway: US$5m
- Serbia: US$4m
- Cuba: US$4m
- Panama: US$4m
- Mexico: US$3m
- Malta: US$3m
- North Macedonia: US$2m
- Colombia: US$2m
- Georgia: US$1m
- United Arab Emirates: US$1m
- Anguilla: US$1m
- Thailand: US$1m
Trade value (US$) no reported trade < US$10mUS$10m+US$195m+US$2bn+> US$7bn
Imports: 209
- United States: US$44bn
- Germany: US$15bn
- Switzerland: US$10bn
- Netherlands: US$9bn
- Japan: US$9bn
- China: US$9bn
- France: US$7bn
- Italy: US$6bn
- United Kingdom: US$6bn
- Canada: US$5bn
- Belgium: US$4bn
- Brazil: US$4bn
- Hungary: US$3bn
- Spain: US$3bn
- Poland: US$3bn
- Ireland: US$2bn
- Russia: US$2bn
- Slovenia: US$2bn
- Australia: US$2bn
- Austria: US$2bn
- Mexico: US$2bn
- South Korea: US$2bn
- Türkiye: US$1bn
- Sweden: US$1bn
- Saudi Arabia: US$1bn
- Czechia: US$1bn
- Romania: US$1bn
- Israel: US$886m
- Taiwan: US$839m
- Greece: US$835m
- Colombia: US$779m
- Singapore: US$755m
- Denmark: US$746m
- Argentina: US$637m
- United Arab Emirates: US$631m
- Portugal: US$575m
- Slovakia: US$560m
- Norway: US$558m
- Finland: US$492m
- Egypt: US$491m
- India: US$475m
- Croatia: US$469m
- Hong Kong SAR China: US$402m
- Kuwait: US$380m
- Serbia: US$321m
- Bulgaria: US$321m
- Chile: US$319m
- Kazakhstan: US$316m
- Iraq: US$300m
- Thailand: US$239m
- Malaysia: US$217m
- Algeria: US$211m
- Lithuania: US$195m
- Costa Rica: US$190m
- Panama: US$178m
- Morocco: US$176m
- Vietnam: US$157m
- South Africa: US$157m
- New Zealand: US$153m
- Qatar: US$152m
Top exporters
| Rank | Country | Value | Share |
|---|---|---|---|
| 1 | US$34bn | 19.8% | |
| 2 | US$31bn | 18.1% | |
| 3 | US$20bn | 11.6% | |
| 4 | US$19bn | 10.9% | |
| 5 | US$11bn | 6.3% | |
| 6 | US$10bn | 5.7% | |
| 7 | US$8bn | 4.6% | |
| 8 | US$7bn | 4.2% | |
| 9 | US$5bn | 3% | |
| 10 | US$5bn | 2.7% |
Top importers
| Rank | Country | Value | Share |
|---|---|---|---|
| 1 | US$44bn | 25.8% | |
| 2 | US$15bn | 8.5% | |
| 3 | US$10bn | 5.8% | |
| 4 | US$9bn | 5.3% | |
| 5 | US$9bn | 5.2% | |
| 6 | US$9bn | 5% | |
| 7 | US$7bn | 3.9% | |
| 8 | US$6bn | 3.6% | |
| 9 | US$6bn | 3.2% | |
| 10 | US$5bn | 2.7% |
Import duty on this product around the world 152
The most-favoured-nation (MFN) duty each country applies to goods of this HS subheading: the average over its national tariff lines, with the lowest and highest line where they differ. Goods from countries with a trade agreement often pay less.
- 0%median duty
- 114number of duty-free countries (MFN)
- 16%highest: Iran, French Polynesia, Pakistan
152
| Importing country | MFN duty | lines from – to | data year |
|---|---|---|---|
| 0% | 2023 | ||
| 5% | 2023 | ||
| 0% | 2023 · HS 2017 | ||
| 0% | 2021 · HS 2017 | ||
| 10% | 2% – 14% | 2023 · HS 2017 | |
| 3% | 2023 | ||
| 2.5% | 0% – 5% | 2023 | |
| 0% | 2023 · HS 2017 | ||
| 0% | 2022 | ||
| 0% | 2023 | ||
| 0% | 2023 · HS 2017 | ||
| 0% | 2022 · HS 2017 | ||
| 3% | 2021 · HS 2017 | ||
| 0% | 2023 | ||
| 0% | 2023 | ||
| 0% | 2023 | ||
| 0% | 2022 | ||
| 3.3% | 0% – 5% | 2023 · HS 2017 | |
| 5% | 2022 | ||
| 0% | 2023 | ||
| 0.7% | 0% – 2% | 2023 · HS 2017 | |
| 0% | 2023 · HS 2017 | ||
| 0% | 2023 | ||
| 0% | 2023 | ||
| 0% | 2023 · HS 2017 | ||
| 5% | 2023 | ||
| 0% | 2023 | ||
| 0% | 2023 · HS 2017 | ||
| 5% | 2023 | ||
| 5% | 2023 | ||
| 6% | 2023 · HS 2017 | ||
| 3% | 2023 | ||
| 0% | 2023 · HS 2017 | ||
| 0% | 2021 · HS 2017 | ||
| 5% | 2023 | ||
| 0% | 2022 · HS 2017 | ||
| 0% | 2023 | ||
| 0% | 2023 · HS 2017 | ||
| 0% | 2023 · HS 2017 | ||
| 0% | 2023 · HS 2017 | ||
| 0% | 2023 | ||
| 0% | 2023 · HS 2017 | ||
| 0% | 2019 · HS 2017 | ||
| 0% | 2022 | ||
| 5% | 2023 | ||
| 0% | 2023 | ||
| 0% | 2021 · HS 2017 | ||
| 0% | 2023 | ||
| 0% | 2023 | ||
| 15% | 2023 | ||
| 5% | 2023 | ||
| 0% | 2023 | ||
| 0% | 2022 · HS 2017 | ||
| 0% | 2023 | ||
| 0% | 2023 · HS 2017 | ||
| 0% | 2023 | ||
| 0% | 2023 | ||
| 0% | 2023 | ||
| 0% | 2023 · HS 2017 | ||
| 0% | 2020 · HS 2017 | ||
| 0% | 2023 | ||
| 0% | 2023 | ||
| 0% | 2023 | ||
| 10% | 2023 | ||
| 0% | 2023 | ||
| 16% | 5% – 32% | 2020 · HS 2017 | |
| 4% | 0% – 8% | 2022 · HS 2017 | |
| 0% | 2023 | ||
| 0% | 2023 | ||
| 0% | 2023 | ||
| 0% | 2023 | ||
| 0% | 2023 | ||
| 0% | 2023 | ||
| 3% | 2021 · HS 2017 | ||
| 5% | 2023 · HS 2017 | ||
| 5% | 2020 · HS 2017 | ||
| 0% | 2023 | ||
| 0% | 2023 | ||
| 0% | 2021 · HS 2017 | ||
| 0% | 2021 · HS 2017 | ||
| 0% | 2023 | ||
| 0% | 2023 | ||
| 0% | 2021 · HS 2017 | ||
| 0% | 2023 | ||
| 0% | 2023 | ||
| 0% | 2023 | ||
| 0% | 2023 · HS 2017 | ||
| 0% | 2023 | ||
| 5% | 0% – 10% | 2023 · HS 2017 | |
| 4% | 2021 · HS 2017 | ||
| 0% | 2023 · HS 2017 | ||
| 5% | 2023 | ||
| 0% | 2023 · HS 2017 | ||
| 2.5% | 2023 | ||
| 0% | 2023 | ||
| 0% | 2023 · HS 2017 | ||
| 0% | 2023 | ||
| 0% | 2021 · HS 2017 | ||
| 0% | 2023 | ||
| 0% | 2023 | ||
| 0% | 2023 | ||
| 0% | 2023 | ||
| 0% | 2023 | ||
| 0% | 2023 | ||
| 0% | 2023 | ||
| 0% | 2023 | ||
| 11% | 2023 | ||
| 4% | 0% – 8% | 2017 · HS 2017 | |
| 0% | 2023 | ||
| 0% | 2023 | ||
| 0.7% | 0% – 2% | 2023 · HS 2017 | |
| 0% | 2023 · HS 2017 | ||
| 1% | 2023 | ||
| 0% | 2023 | ||
| 3% | 2021 · HS 2017 | ||
| 0% | 2023 | ||
| 0% | 2020 · HS 2017 | ||
| 5% | 2019 · HS 2017 | ||
| 0% | 2023 | ||
| 0% | 2023 | ||
| 0% | 2023 | ||
| 0% | 2023 | ||
| 0% | 2023 · HS 2017 | ||
| 5% | 2023 · HS 2017 | ||
| 5% | 2023 · HS 2017 | ||
| 0% | 2023 | ||
| 0% | 2023 | ||
| 0% | 2023 | ||
| 0% | 2023 | ||
| 0% | 2021 · HS 2017 | ||
| 0% | 2023 | ||
| 0% | 2021 · HS 2017 | ||
| 0% | 2023 | ||
| 0% | 2023 | ||
| 0% | 2023 | ||
| 0% | 2023 | ||
| 0% | 2023 · HS 2017 | ||
| 0% | 2023 | ||
| 0% | 2017 · HS 2017 | ||
| 0% | 2023 | ||
| 0% | 2023 · HS 2017 | ||
| 0% | 2023 | ||
| 0% | 2023 | ||
| 0% | 2023 | ||
| 0.7% | 0% – 2% | 2023 · HS 2017 | |
| 0% | 2021 · HS 2017 | ||
| 0% | 2023 | ||
| 1.2% | 0% – 2% | 2023 · HS 2017 | |
| 0% | 2023 | ||
| 5% | 2017 · HS 2017 | ||
| 0% | 2023 | ||
| 0% | 2023 |
Tariff data years 2017–2023; rates may have changed since. · UNCTAD TRAINS, accessed via WITS (World Bank)
Classifications and correspondences
Where this HS subheading sits in the United Nations' statistical classifications, and which codes it had in earlier editions of the Harmonized System.
- SITC Rev. 4
- 54163 Antisera & other blood fractions; vaccines
- End use (BEC Rev. 5)
- Intermediate goods · BEC 711220
- CPC 2.1 product
- 35270 Other pharmaceutical products
- ISIC Rev. 4 activity
- 2100 Manufacture of pharmaceuticals, medicinal chemical and botanical products
Earlier HS editions
| HS | Code | |
|---|---|---|
| 2017 | 3002.15 | changed |
| 2012 | 3002.10 | changed |
| 2007 | 2925.29, 2933.29, 2934.99, 2937.90, 3002.10, 3002.20, 3002.90, 3907.20 | changed |
| 2002 | 2925.20, 2933.29, 2934.99, 2937.90, 3002.10, 3002.20, 3002.90, 3907.20 | changed |
| 1996 | 2925.20, 2933.29, 2933.90, 2934.90, 2937.99, 3002.10, 3002.20, 3002.90, 3907.20 | changed |
| 1992 | 2925.20, 2933.29, 2933.59, 2933.90, 2934.90, 2937.99, 3002.10, 3002.20, 3002.90, 3907.20 | changed |
Correspondence tables of the United Nations Statistics Division (UNSD)
Binding rulings for similar goods 18
Decisions of U.S. Customs and Border Protection (CROSS) and HMRC (Advance Tariff Rulings) on goods classified here. A ruling binds only its holder, but shows how the authorities classify similar goods. The descriptions are the authorities’ own, in English.
- N363467 U.S. CBP
The tariff classification of ZIEXTENZO® (pegfilgrastim-bmez) Injection in dosage form, from Austria
- N350948 U.S. CBP
The tariff classification of HEC88473 Drug Product (also known as APL-18881) in dosage form, from China
- N335649 U.S. CBP
The tariff classification of Hyrimoz® (adalimumab-adaz) Injection in dosage form, from Austria
- N331005 U.S. CBP
The tariff classification of clinical trial kits from the United States
- N314693 U.S. CBP
The tariff classification of various recombinant proteins packed for retail sale from India
- N313862 U.S. CBP
The tariff classification of HRP Conjugated antibodies from India
- 600011801 HMRC
Diagnostic slides to detect antibodies in serum. Designed to diagnose autoimmune diseases. The product has a tissue substrate (which is the endomysial antigen (EMA-IgA)) on the slide which is produced from an animal by product. Using cryotomy a frozen section of biological material is attached to…
18 rulings in total for this code
Recent rule changes mentioning this code
Acts whose text cites this code or its heading. Check the act itself: a code can be cited for reasons other than a change of its duty.
-
FR Doc. 2026-19498 · 91 FR 60360 · Source: federalregister.gov
-
FR Doc. 2026-14542 · 91 FR 45516 · Source: federalregister.gov
-
FR Doc. 2026-11158 · 91 FR 33854 · Source: federalregister.gov
-
CELEX 32026R0360 · Source: eur-lex.europa.eu
Code history
Since 2017; before, these goods were classified under 3002.10.
Subheading 3002.15 is a single line in the UK Global Tariff, where the duty is duty-free.
The EU Combined Nomenclature has one tariff line for subheading 3002.15; the duty is duty-free.
Goods from 156 countries can enter the UK at a preferential rate instead of the standard Free; 156 of them pay no duty at all, for example under DCTS Comprehensive or European Union.
In the UK, additional duty of 35% applies on top of the customs duty to goods from Belarus and Russia.
In the 12 months to August 2026, the UK imported immunological products, dosed or retail worth £5.1bn (up 18% on the year before), at an average of £2,400.11 per kg; Germany supplied 19%, followed by Ireland.
World trade in immunological products, dosed or retail reached US$172bn in 2024, up 16.3% on 2023.
Switzerland was the largest exporter with 19.8% of the total, ahead of Germany.
Questions and answers
What is the HS code for immunological products, put up in measured doses or in forms or packings for retail sale?
Immunological products, put up in measured doses or in forms or packings for retail sale fall under HS subheading 3002.15, part of heading 3002, in section VI of the Harmonized System.
What is the import duty on immunological products, put up in measured doses… in the UK?
Under the UK Global Tariff, imports under 3002.15 from countries without a preferential agreement are free of duty. Preferential rates, anti-dumping duties and VAT are not included.
What is the import duty on immunological products, put up in measured doses… in the EU?
Under the EU Combined Nomenclature, imports under 3002.15 from countries without a preferential agreement are free of duty. Preferential rates, anti-dumping duties and VAT are not included.
Which country exports the most immunological products, put up in measured doses…?
Switzerland, with US$34bn in 2024 (19.8% of world exports).
Which countries can export immunological products, dosed or retail to the UK duty-free?
156 countries pay no duty under a trade agreement or preference scheme, among them partners under DCTS Comprehensive, European Union, CARIFORUM. The goods must meet the agreement’s rules of origin and the importer needs proof of origin; otherwise the standard rate of Free applies. Pick a country above to see its rate.
Is there anti-dumping duty on immunological products, dosed or retail?
The UK charges additional duty of 35% on goods from Belarus and Russia. Lower rates apply to the named exporters listed in the measure.
Where does the UK import immunological products, dosed or retail from?
In the 12 months to August 2026, the largest suppliers were Germany (19%), Ireland (17%) and United States (17%), out of total imports of £5.1bn.